DBP B Share Price Performance
SEK 0.11
-0.27 (-71.73%)
Price SEK 0.11
Share Pricen/a
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
DBP B Community Narratives
There are no narratives available yet.
There are no community narratives available.
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Double Bond Pharmaceutical International AB (publ) Key Details
Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
n/a
- -0.053
- 101.79%
- -79.20%
- 0%
About DBP B
- Founded
- 2014
- Employees
- 9
- CEO
- WebsiteView website
Double Bond Pharmaceutical International AB (publ), a pharmaceutical company, engages in the development and commercialization of approaches for the treatment of oncological and infectious diseases. It offers Temodex/SI-053, a therapy to treat malignant brain tumors; and SA033, a therapy to treat cancers in liver. The company is also developing Belopenem for the treatment of bacterial pneumonia. Double Bond Pharmaceutical International AB (publ) was incorporated in 2014 and is based in Uppsala, Sweden.
